Review
Clinical development of Orthoclone OKT3
- PMID: 3105142
Item in Clipboard
Review
Clinical development of Orthoclone OKT3
Transplant Proc.
1987 Apr.
No abstract available
Similar articles
-
Comparison between prophylactic use of OKT3 and cyclosporine in cadaveric renal transplantation.Transplant Proc. 1990 Aug;22(4):1759-60. Transplant Proc. 1990. PMID: 2117800 Clinical Trial. No abstract available.
-
Use of Orthoclone OKT3 monoclonal antibody to reverse acute renal allograft rejection unresponsive to treatment with conventional immunosuppressive regimens.Transplant Proc. 1987 Apr;19(2 Suppl 1):28-31. Transplant Proc. 1987. PMID: 3105137 Clinical Trial. No abstract available.
-
Overview of the development of Orthoclone OKT3: monoclonal antibody for therapeutic use in transplantation.Transplant Proc. 1987 Apr;19(2 Suppl 1):1-6. Transplant Proc. 1987. PMID: 3105134 Review. No abstract available.
-
A U.S. clinical study of Orthoclone OKT3 in renal transplantation.Transplant Proc. 1987 Apr;19(2 Suppl 1):21-7. Transplant Proc. 1987. PMID: 3105136 Clinical Trial. No abstract available.
-
Acute renal allograft rejection: the role of monoclonal antibodies in treatment: experience with orthoclonal anti-T3 cell antibody.East Afr Med J. 1990 Sep;67(9):667-73. East Afr Med J. 1990. PMID: 2123786 Review.
Cited by
-
The use of therapeutic drug monitoring to optimise immunosuppressive therapy.Clin Pharmacokinet. 1996 Feb;30(2):107-40. doi: 10.2165/00003088-199630020-00003. Clin Pharmacokinet. 1996. PMID: 8906895 Review.
-
Cytokine release and dynamics of leukocyte populations after CD3/TCR monoclonal antibody treatment.J Clin Immunol. 1992 May;12(3):170-7. doi: 10.1007/BF00918085. J Clin Immunol. 1992. PMID: 1400897
-
Phase I trial of a humanized, Fc receptor nonbinding anti-CD3 antibody, hu12F6mu in patients receiving renal allografts.MAbs. 2010 Jul-Aug;2(4):449-56. doi: 10.4161/mabs.12305. Epub 2010 Jul 1. MAbs. 2010. PMID: 20519962 Free PMC article. Clinical Trial.
-
Contemporary Monoclonal Antibody Utilization in Glomerular Diseases.Mayo Clin Proc Innov Qual Outcomes. 2023 Jun 30;7(4):276-290. doi: 10.1016/j.mayocpiqo.2023.04.009. eCollection 2023 Aug. Mayo Clin Proc Innov Qual Outcomes. 2023. PMID: 37448529 Free PMC article. Review.
-
Prevention and management of the adverse effects associated with immunosuppressive therapy.Drug Saf. 1993 Aug;9(2):104-31. doi: 10.2165/00002018-199309020-00004. Drug Saf. 1993. PMID: 8397889 Review.
Publication types
MeSH terms
Substances
Grants and funding
LinkOut - more resources
Other Literature Sources